Which of the following drugs has a high affinity for 5-HT2 receptors in the brain, does not cause extrapyramidal dysfunction or hematotoxicity, and is repoed to increase the risk of significant QT prolongation?
**Core Concept**
The question is testing the student's knowledge of the pharmacological properties of various antipsychotic medications, specifically their affinity for serotonin receptors, side effect profiles, and cardiac risks.
**Why the Correct Answer is Right**
The correct answer is a type of atypical antipsychotic that has a high affinity for 5-HT2 receptors in the brain. This receptor binding profile contributes to its efficacy in treating psychosis with a lower risk of extrapyramidal side effects (EPS) compared to typical antipsychotics. Additionally, this class of medication is known to have a higher risk of QT prolongation due to its effects on cardiac potassium channels.
**Why Each Wrong Option is Incorrect**
**Option A:** Haloperidol is a typical antipsychotic that has a high affinity for dopamine D2 receptors, not serotonin 5-HT2 receptors. It is associated with a higher risk of EPS and hematotoxicity.
**Option B:** Risperidone is an atypical antipsychotic that has a high affinity for 5-HT2 receptors, but it has a moderate risk of EPS and does not significantly prolong the QT interval.
**Option C:** Olanzapine is another atypical antipsychotic that has a high affinity for 5-HT2 receptors, but it is not specifically known for increasing the risk of significant QT prolongation.
**Clinical Pearl / High-Yield Fact**
Atypical antipsychotics with a high affinity for 5-HT2 receptors are generally preferred in patients at risk for EPS, but their use should be carefully monitored for cardiac risks, particularly QT prolongation.
**Correct Answer:** C. Quetiapine